Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1961795 (GSK4112, SR6452) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Liver X receptor-α/LXR-alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2808] [GtoPdb: 602] [UniProtKB: Q13133] | ||||||||
ChEMBL | Binding affinity to LXRalpha (unknown origin) by radioligand displacement assay | B | 5.3 | pIC50 | 5000 | nM | IC50 | J Med Chem (2013) 56: 4729-4737 [PMID:23656296] |
Rev-Erb-α/Nuclear receptor subfamily 1 group D member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1961783] [GtoPdb: 596] [UniProtKB: P20393] | ||||||||
GtoPdb | - | - | 5.64 | pIC50 | 2300 | nM | IC50 | ACS Chem Biol (2011) 6: 131-4 [PMID:21043485] |
ChEMBL | Agonist activity at Rev-erbalpha assessed as repression of transcription by luciferase-reporter gene assay | F | 5.64 | pEC50 | 2300 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 3739-3742 [PMID:22560469] |
ChEMBL | Agonist activity at Rev-Erbalpha expressed in HEK293 cells coexpressing BamII promoter assessed as repression of transcription after 24 hrs by dual-Glo luciferase assay | F | 5.64 | pEC50 | 2300 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 4413-4417 [PMID:22633688] |
ChEMBL | Agonist activity at Rev-Erb alpha (unknown origin) by FRET assay | B | 5.64 | pEC50 | 2300 | nM | EC50 | Bioorg Med Chem Lett (2020) 30: 127395-127395 [PMID:32738989] |
ChEMBL | Agonist activity at biotinylated REV-ERBalpha (unknown origin) assessed as increase in biotinylated NCOR peptide recruitment after 1 hr by FRET assay | B | 6.3 | pEC50 | 500 | nM | EC50 | J Med Chem (2013) 56: 4729-4737 [PMID:23656296] |
ChEMBL | Agonist activity at Rev-erbalpha assessed as NCoR recruitment by FRET assay | F | 6.4 | pEC50 | 400 | nM | EC50 | Bioorg Med Chem Lett (2012) 22: 3739-3742 [PMID:22560469] |
GtoPdb | - | - | 6.4 | pEC50 | 400 | nM | EC50 | ACS Chem Biol (2010) 5: 925-32 [PMID:20677822] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]